A Phase II Evaluation of Flavopiridol (NSC 649890) in the Treatment of Recurrent or Persistent Endometrial Carcinoma
Phase of Trial: Phase II
Latest Information Update: 21 Jun 2013
At a glance
- Drugs Alvocidib (Primary)
- Indications Endometrial cancer
- Focus Therapeutic Use
- 30 Jun 2009 Additional lead trial investigator (Cracchiolo B) added as reported by New Jersey Cancer Trial Connect record.
- 30 Jun 2009 New source identified and integrated (New Jersey Cancer Trial Connect)
- 25 Sep 2005 New trial record.